Page 149 - DUOKOPT BIBLIOBOOK

EFFICACY

Acta Ophthalmologica 2010

Advanced Glaucoma Intervention Study timolol combination to monotherapy with on the retinal circulation. Acta Ophthalmol
Investigators (2002): The Advanced Glau- timolol or dorzolamide. Dorzolamide– 75: 236–238.
coma Intervention Study (AGIS) (12). Timolol Combination Study Group. Oph- Hageman GS, Zhu XL, Waheed A & Sly WS
Baseline risk factors for sustained loss of thalmology 105(10): 1952–1959. (1991): Localization of carbonic anhydrase
visual field and visual acuity in patients Dong J & Chihara E (2001): Slope analysis IV in a specific capillary bed of the human
with advanced glaucoma. Am J Ophthal- of the optic disc in eyes with ocular hyper- eye. Proc Natl Acad Sci U S A 88: 2716–
mol 134:499–512. tension and early normal-tension glaucoma 2720.
Armaly MF, Krueger DE, Maunder L et al. by confocal scanning laser ophthalmo- Hodapp E, Parrish R & Anderson D (1993):
(1980): Biostatistical analysis of the Collab- scope. Br J Ophthalmol 85: 56–62. Clinical Decisions in Glaucoma. St Louis.
orative Glaucoma Study I. Summary Drance SM & Rojanapongpun P (1995): The MO: Mosby-Year Book, Inc., 52–59.
report of the risk factors for glaucomatous ophthalmic artery velocity in open-angle Holmin C & Krakau CE (1982): Regression
visual field defects. Arch Ophthalmol 98: glaucoma. In: Drance SM (ed.). Update to analyses of the central visual field in
2163–2171. Glaucoma, Ocular Blood Flow, and Drug chronic glaucoma cases: a follow-up study
Asman P & Heijl A (1992): Glaucoma Hemi- Treatment. New York, NY: Kluger Publi- using automatic perimetry. Acta Ophthal-
field Test. Automated visual field evalua- cations 55–56. mol (Copenh) 60: 267–274.
tion. Arch Ophthalmol 110: 812–819. Drance S, Anderson DR, Schulzer M & the Inoue J, Oka M, Aoyama Y, Kobayashi S,
Avunduk AM, Sari A, Akyol N, Oztu ¨ rk O, Collaborative Normal-Tension Glaucoma Ueno S, Hada N, Takeda T & Takehana
Kapicioglu Z & Erdo ¨ l H (2001): The Study Group (2001): Risk factors for pro- M (2004): Effects of dorzolamide hydro-
1-month effects of topical betaxolol, dorzo- gression of visual field abnormalities in chloride on ocular tissues. J Ocul Pharma-
lamide and apraclonidine on ocular blood normal-tension glaucoma. Am J Ophthal- col Ther 20: 1–13.
flow velocities in patients with newly mol 131: 699–708. Jansonius NM & Heeg GP (2009): The Gron-
diagnosed primary open-angle glaucoma. European Glaucoma Prevention Study ingen Longitudinal Glaucoma Study II. A
Ophthalmologica 215: 361–365. (EGPS) Group (2005): Results of the Euro- prospective comparison of frequency
Bengtsson B, Leske MC, Hyman L, Heijl A pean Glaucoma Prevention Study. Oph- doubling perimetry, the GDx nerve fibre
& the Early Manifest Glaucoma Trial thalmology 112: 366–375. analyser and standard automated perimetry
Group (2007): Fluctuation of intraocular European Glaucoma Prevention Study in glaucoma suspect patients. Acta Oph-
pressure and glaucoma progression in the (EGPS) Group (2007): Predictive factors thalmol 87: 429–432.
Early Manifest Glaucoma Trial. Ophthal- for open-angle glaucoma among patients Januloviciene ¨ I, Harris A, Kagemann L, Siesky
mology 114: 205–209. with ocular hypertension in the European B & Mc Cranor L (2004): A comparison of
Bergstrand IC, Heijl A & Harris A (2002): Glaucoma Prevention Study. Ophthalmol- the effects of dorzolamide ⁄ timolol fixed
Dorzolamide and ocular blood flow in pre- ogy 114: 3–9. combination versus letterpress in intraocular
viously untreated glaucoma patients: a con- Fitzke FW, Hitchings RA, Poinoosawmy D, pressure and pulsatile ocular blood flow in
trolled double-masked study. Acta McNaught AI & Crabb DP (1996): Analy- primary open-angle glaucoma patients. Acta
Ophthalmol Scand 80: 176–182. sis of visual field progression in glaucoma. Ophthalmol Scand 82: 730–737.
Boyle JE, Ghosh K, Gieser DK & Adamsons Br J Ophthalmol 80: 40–48. Josefsson A, Sigurdsson SB, Bang K & Eysteins-
IA (1998): A randomized trial comparing Friberg L, Kastrup J, Rizzi D, Jensen JB & son T (2004): Dorzolamide induces vasodila-
the dorzolamide–timolol combination given Lassen NA (1990): Cerebral blood flow tation in isolated pre-contracted bovine
twice daily to monotherapy with timolol and end-tidal pCO 2 during prolonged acet- retinal arteries. Exp Eye Res 78: 215–221.
and dorzolamide. Dorzolamide–Timolol azolamide treatment in humans. Am J Katz J, Zeger S & Liang KY (1994): Appropri-
Study Group. Ophthalmology 105(10): Physiol 258: 954–959. ate statistical methods to account for similar-
1945–1951. Friedman E & Chandra SR (1972): Choroidal ities in binary outcomes between fellow eyes.
Chauhan BC (2007): Choosing end-points in blood flow: effects of oxygen and carbon Invest Ophthalmol Vis Sci 35: 2461–2465.
clinical studies and trials. Eye 21 (Suppl.): dioxide. Arch Ophthalmol 87: 70–71. Katz J, Gilbert D, Quigley HA & Sommer A
34–37. Fuchsja ¨ ger-Mayrl G, Wally B, Rainer G (1997): Estimating progression of visual
Chauhan BC, Mikelberg FS, Balaszi AG, et al. (2005): Effect of dorzolamide and field loss in glaucoma. Ophthalmology 104:
Le Blanc RP, Lesk MR, Trope GE, for the timolol on ocular blood flow in patients 1017–1025.
Canadian Glaucoma Study Group (2008): with primary open-angle glaucoma and Katz J, Congdon N & Friedman DS (1999):
Canadian Glaucoma Study 2: risk factors ocular hypertension. Br J Ophthalmol 89: Methodological variations in estimating
for the progression of open-angle glau- 1293–1297. apparent progressive visual field loss in
coma. Arch Ophthalmol 126: 1030–1036. Galassi F, Sodi A, Renieri G, Ucci F, Pieri clinical trials of glaucoma treatment. Arch
Chen PP (2002): Correlation of visual field B, Harris A & Siesky B (2002): Effects of Ophthalmol 117: 1137–1142.
progression between eyes in patients with timolol and dorzolamide on retrobulbar Kaup M, Plange N, Niegel M, Remky A &
open-angle glaucoma. Ophthalmology 109: haemodynamics in patients with newly Arend O (2004): Effects of brinzolamide on
2093–2099. diagnosed primary open-angle glaucoma. ocular haemodynamics in healthy volun-
Chen PP & Bhandari A (2000): Fellow eye Ophthalmologica 216: 123–128. teers. Br J Ophthalmol 88: 257–262.
prognosis in patients with severe visual field Galassi F, Sodi A, Ucci F, Renieri G, Pieri B Kehler AK, Holmgaard K, Hessellund A, Aalkj-
loss in one eye from chronic open-angle & Baccini M (2003): Ocular haemodynam- aer C & Bek T (2007): Variable involvement
glaucoma. Arch Ophthalmol 118: 473–478. ics and glaucoma prognosis: a colour of the perivascular retinal tissue in carbonic
Chen PP & Park RJ (2000): Visual field Doppler imaging study. Arch Ophthalmol anhydrase inhibitor-induced relaxation of
progression in patients with initially unilat- 121: 1711–1715. porcine retinal arterioles in vitro. Invest Oph-
eral visual field loss from chronic open-angle Gordon MO, Beiser JA, Brand JD et al. thalmol Vis Sci 48: 4688–4693.
glaucoma. Ophthalmology 107: 1688–1692. (2002): The Ocular Hypertension Treat- Lass JH, Khosrof SA, Laurence JK, Horwitz
Chow S & Ruskey E (2004): Drawing area- ment Study: baseline factors that predict B, Ghosh K & Adamsons I (1998): A dou-
proportional Venn and Euler diagrams. In: the onset of primary open-angle glaucoma. ble-masked, randomized, 1-year study com-
Proc. of Graph Drawing 2003. Spring- Arch Ophthalmol 120: 714–720. paring the corneal effects of dorzolamide,
Verlag LNCS 2912. 466–477. Grant WM & Burke JF Jr (1982): Why do timolol, and betaxolol. Dorzolamide
Clineschmidt CM, Williams RD, Snyder E & some people go blind from glaucoma? Corneal Effects Study Group. Arch Oph-
Adamsons IA (1998): A randomized trial Ophthalmology 89: 991–998. thalmol 116: 1003–1010.
in patients inadequately controlled with Grunwald JE, Mathur S & DuPont J (1997): Leske MC, Heijl A, Hussein M, Bengtsson B,
timolol alone comparing the dorzolamide– Effects of dorzolamide hydrochloride 2% Hyman L, Komaroff E; Early Manifest

551 149